Latremouille-Viau D - Search Results

1

Economic impact of switching from valsartan to other angiotensin receptor blockers in patients with hypertension.

Signorovitch J, Zhang J, Wu EQ, Latremouille-Viau D, Yu AP, Dastani HB, Kahler KH. Signorovitch J, et al. Curr Med Res Opin. 2010 Apr;26(4):849-60. doi: 10.1185/03007991003613910. Curr Med Res Opin. 2010. PMID: 20141381

2

Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting.

LeLorier J, Duh MS, Paradis PE, Latrémouille-Viau D, Lefebvre P, Manjunath R, Sheehy O. LeLorier J, et al. Curr Med Res Opin. 2008 Apr;24(4):1069-81. doi: 10.1185/030079908x280572. Epub 2008 Feb 29. Curr Med Res Opin. 2008. PMID: 18315941

3

Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries.

Paradis PE, Latrémouille-Viau D, Moore Y, Mishagina N, Lafeuille MH, Lefebvre P, Gaudig M, Duh MS. Paradis PE, et al. Curr Med Res Opin. 2009 Jul;25(7):1793-805. doi: 10.1185/03007990903044374. Curr Med Res Opin. 2009. PMID: 19505202

4

The risks and costs of multiple-generic substitution of topiramate.

Duh MS, Paradis PE, Latrémouille-Viau D, Greenberg PE, Lee SP, Durkin MB, Wan GJ, Rupnow MF, LeLorier J. Duh MS, et al. Neurology. 2009 Jun 16;72(24):2122-9. doi: 10.1212/WNL.0b013e3181aa5300. Neurology. 2009. PMID: 19528520

5

High prevalence of potential drug-drug interactions for psoriasis patients prescribed methotrexate or cyclosporine for psoriasis: associated clinical and economic outcomes in real-world practice.

Saurat JH, Guérin A, Yu AP, Latremouille-Viau D, Wu EQ, Gupta SR, Bao Y, Mulani PM. Saurat JH, et al. Dermatology. 2010;220(2):128-37. doi: 10.1159/000275198. Epub 2010 Feb 3. Dermatology. 2010. PMID: 20130383 Free article.

6

Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis.

Kimball AB, Guerin A, Latremouille-Viau D, Yu AP, Gupta S, Bao Y, Mulani P. Kimball AB, et al. Am J Med. 2010 Apr;123(4):350-7. doi: 10.1016/j.amjmed.2009.08.022. Am J Med. 2010. PMID: 20362755

7

Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy.

Wu EQ, Forsythe A, Guérin A, Yu AP, Latremouille-Viau D, Tsaneva M. Wu EQ, et al. Am J Ther. 2012 Nov;19(6):e157-66. doi: 10.1097/MJT.0b013e31820543c5. Am J Ther. 2012. PMID: 21317625

8

Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution.

Sawicki GS, Signorovitch JE, Zhang J, Latremouille-Viau D, von Wartburg M, Wu EQ, Shi L. Sawicki GS, et al. Pediatr Pulmonol. 2012 Jan;47(1):44-52. doi: 10.1002/ppul.21521. Epub 2011 Aug 3. Pediatr Pulmonol. 2012. PMID: 21815282

9

A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care.

Sawicki GS, Ayyagari R, Zhang J, Signorovitch JE, Fan L, Swallow E, Latremouille-Viau D, Wu EQ, Shi L. Sawicki GS, et al. Pediatr Pulmonol. 2013 Oct;48(10):954-61. doi: 10.1002/ppul.22741. Epub 2012 Dec 19. Pediatr Pulmonol. 2013. PMID: 23255309

10

Distribution and drivers of costs in type 2 diabetes mellitus treated with oral hypoglycemic agents: a retrospective claims data analysis.

Bron M, Guerin A, Latremouille-Viau D, Ionescu-Ittu R, Viswanathan P, Lopez C, Wu EQ. Bron M, et al. J Med Econ. 2014 Sep;17(9):646-57. doi: 10.3111/13696998.2014.925905. Epub 2014 Jun 24. J Med Econ. 2014. PMID: 24959693 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters